Intimation of closure of trading window from as detailed in the letter attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mahamaya Lifesciences has informed the stock exchange that its trading window will remain closed starting November 24, 2025, until 48 hours after the company announces its unaudited financial results for the quarter ended September 30, 2025. During this window, all designated persons including employees, directors, auditors, and their immediate relatives are barred from buying or selling the company's shares. This is a routine compliance measure under SEBI's insider trading rules and signals that the Q2 results announcement is approaching. The exact date of the board meeting to approve the results will be communicated separately in due course.
This is a standard regulatory filing with no direct impact on the stock price. Retail investors should watch for the upcoming Q2 FY26 results announcement, which could be a potential trigger for price movement based on the numbers declared.